Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 6/20 | 0.52 |
| ▸ | LPL | P06858 | 11/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13058013 | 0.92 | LIPG (0.46) | ALOX5LPLLIPGPRMT5WDR77 | |
| SCHEMBL28726419 | 0.83 | LIPG (0.56) | ALOX5LPLLIPGHTR2B | |
| SCHEMBL30869831 | 0.82 | LIPG (0.46) | ALOX5LPLLIPG | |
| SCHEMBL47074 | 0.82 | LPL (0.53) | LPLLIPG | |
| SCHEMBL10171009 | 0.77 | ALDH1A1 (0.41) | LPLLIPGPRMT5WDR77 | |
| SCHEMBL17065892 | 0.77 | LIPG (0.47) | LPLLIPGPRMT5WDR77 | |
| SCHEMBL10074112 | 0.77 | LPL (0.48) | LPLLIPG | |
| SCHEMBL10074115 | 0.77 | LPL (0.48) | LPLLIPG | |
| SCHEMBL30951705 | 0.76 | LIPG (0.41) | ALOX5LPLLIPGPRMT5WDR77 | |
| SCHEMBL22217016 | 0.76 | LIPG (0.46) | LPLLIPGPRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10935862-B2 | Electrochromic compound, electrochromic composition, and electrochromic display element | RICOH COMPANY, LTD. (JP) | 2021-03-02 | — | — | US | disclosed |
| EP-3660123-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | Ricoh Company, Ltd. (JP) | 2020-06-03 | — | — | EP | disclosed |
| US-20200089070-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | YAMAMOTO SATOSHI (JP) | 2020-03-19 | — | — | US | disclosed |
| EP-3310877-B1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | RICOH CO LTD (JP) | 2020-02-26 | — | — | EP | disclosed |
| US-20180173070-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2018-06-21 | — | — | US | disclosed |
| US-20180173070-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2018-06-21 | — | — | US | disclosed |
| WO-2016203773-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2016-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180173070-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | RPS23, RPS18, RPL13 | ALOX5 4800/4885LPL 3489/4885LIPG 3081/4885 |
| US-10935862-B2 | Electrochromic compound, electrochromic composition, and electrochromic display element | RPS23, RPS18, RPL13 | ALOX5 4800/4885LPL 3489/4885LIPG 3081/4885 |
| US-20200089070-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | RPS23, RPS18, RPL13 | ALOX5 4800/4885LPL 3489/4885LIPG 3081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.